Skip Navigation

Improving the Quality of Life of Latin American Patients

M8 provides healthcare professionals and patients with access to proven treatments they need to thrive. We serve as a comprehensive source of expertise in each of the following therapeutic areas.

Reliable, Convenient Service and Support for Professionals and Patients

Get in Touch

Partner with Us

From go-to-market strategy and registration to access and long-term market presence, M8 is a purpose-built biopharmaceutical platform that supports the entire development-commercialization continuum.

Partnerships

Our Commitment to Latin America

Six core values guide us on our mission to provide support to the patients and healthcare professionals of Latin America.

Core Values

Risperdal®

Generic: Risperidone

Description

RISPERDAL® is indicated for the treatment of a wide range of patients with schizophrenia, including first-episode psychosis, acute exacerbation of schizophrenia, chronic schizophrenia, and other psychotic conditions with positive signs (hallucinations, delusions, illusions, thought disturbances, hostility) and/or negative symptoms (such as: affective flattening, emotional and social withdrawal, decreased expression, language poverty). RISPERDAL® relieves affective symptoms (such as depression, feelings of guilt, etc.) associated with schizophrenia. RISPERDAL® is also effective in maintaining clinical improvement during continued therapy in patients who have responded to initial treatment.